The MBA pim in Germany is one of the leading pharmaceutical markets in the world with a total turnover of around €50 billion in 2016. The German pharmaceutical industry comprises about 400 companies employing around 110,000 people. The industry is dominated by a small number of large companies such as Bayer Boehringer Ingelheim Merck KGaA and Sanofi-Aventis.
The German pharmaceutical market is the third largest in the European Union and the ninth largest in the world. In terms of value the German market is the fourth largest in Europe and the tenth largest globally. The German market is also one of the most innovative and research-intensive markets in the world.

Pharmaceutical Industry
The pharmaceutical industry in Germany generated around 35.8 billion euros in revenue in 2018 making it the fourth largest pharmaceutical market in Europe. The German market is expected to grow at a compound annual growth rate (CAGR) of 2.5% between 2019 and 2025 to reach a value of approximately 43.5 billion euros by 2025.
The German pharmaceutical industry is characterized by a large number of small and medium-sized enterprises (SMEs) which account for more than 90% of all companies in the sector. The top 10 companies account for approximately 60% of the total market value. The largest companies in the sector are Boehringer Ingelheim Bayer Merck KGaA and Sanofi-Aventis Deutschland.
The German pharmaceutical market is highly regulated with controls and reimbursement policies that limit pricing flexibility and profitability. In recent years the government has

Pharmaceutical Management
Pharmaceutical management is the scientific discipline concerned with the discovery development regulation and marketing of drugs. It includes all aspects of the therapeutic use of drugs from their discovery and development through to their manufacture packaging and distribution as well as their clinical use and efficacy.
The pharmaceutical industry is a highly regulated sector with strict rules governing the manufacture distribution and marketing of drugs. In order to be able to sell their products companies must first obtain a licence from the relevant authorities. This process can be lengthy and expensive and often requires the submission of extensive clinical data.
Once a drug has been licensed it must be manufactured to strict quality standards and packaged in a way that meets all legal requirements. It must then be distributed through an authorized network of wholesalers and pharmacies. Finally it must be prescribed by a qualified healthcare professional and dispensed by a registered pharmacy.